Medicines Co. (MDCO) Misses Q2 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Income before income taxes: -86.2M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Income before income taxes: -86.2M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q2 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $90.5 million versus the consensus estimate of $122.58 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Personalis, Inc. (PSNL) Misses Q3 EPS by 6c
- Eversource Energy (ES) Tops Q3 EPS by 18c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
